Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil in Mild Cognitive Impairment (MCI)
NCT00293176Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2003
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of donepezil in Mild Cognitive Impairment (MCI), sponsored by Eisai Co., Ltd.. Started Dec 2003; status: completed.
02
Drugs
donepezil
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT00293176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00293176.